v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Net sales $ 544,548 $ 493,842 $ 1,557,577 $ 1,420,156
Cost of goods sold (excluding amortization expense - See Note 13) 351,025 312,977 998,115 906,308
Gross profit 193,523 180,865 559,462 513,848
Selling, general and administrative expenses 136,407 126,479 412,657 372,125
Impairment charges 0 0 0 88,840
Restructuring and related charges, net 8,263 7,745 23,760 31,128
Operating income 48,853 46,641 123,045 21,755
Other expense, net (797) (270) (414) (1,632)
Interest expense (10,023) (10,941) (29,775) (33,265)
Income (loss) before taxes and equity in net income of associated companies 38,033 35,430 92,856 (13,142)
Taxes on income before equity in net income of associated companies 11,830 9,266 30,147 22,280
Income (loss) before equity in net income of associated companies 26,203 26,164 62,709 (35,422)
Equity in net income of associated companies 3,767 4,322 13,816 12,262
Net income (loss) 29,970 30,486 76,525 (23,160)
Less: Net (loss) income attributable to noncontrolling interest (7) 17 44 29
Net income (loss) attributable to Quaker Chemical Corporation $ 29,977 $ 30,469 $ 76,481 $ (23,189)
Per share data:        
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 1.74 $ 1.75 $ 4.43 $ (1.32)
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) 1.73 1.75 4.40 (1.32)
Dividends declared (in dollars per share) $ 0.530 $ 0.508 $ 1.546 $ 1.478